Managing the J-Curve Phenomenon in Hypertension

Understanding the J-Curve Phenomenon

The American College of Cardiology and other guideline societies suggest that blood pressure should be carefully managed to maintain diastolic blood pressure between 70-85 mmHg and systolic blood pressure between 130-140 mmHg to minimize cardiovascular risk in patients experiencing the J-curve phenomenon 1, 2, 3
Hypertension (≥140/90 mmHg) increases cardiovascular risk through well-established mechanisms, as noted by the American Heart Association 4, 5
Excessive blood pressure reduction, particularly diastolic pressure below 70 mmHg, may compromise coronary perfusion and increase cardiovascular events, especially in patients with coronary artery disease, according to the American College of Cardiology 2, 3

The European Society of Cardiology recommends evaluating cardiovascular risk factors and comorbidities, including presence of coronary artery disease, left ventricular hypertrophy, or diabetes, and calculating cardiovascular risk using validated tools (SCORE, QRISK2, or ASCVD risk calculator) 2, 4, 6
Blood pressure should be measured using validated devices with appropriate cuff size, taking multiple readings, as suggested by the American Heart Association 4, 6

The American College of Cardiology recommends targeting systolic BP: 130-140 mmHg and diastolic BP: 70-85 mmHg for a 50-year-old patient without significant comorbidities 1, 4, 7
For patients with coronary artery disease, diastolic BP should be maintained above 70 mmHg, preferably 80-85 mmHg, according to the European Society of Cardiology 2, 3
Lifestyle modifications, including dietary approaches (DASH diet), sodium restriction, weight management, regular physical activity, and limited alcohol consumption, are recommended by the American Heart Association 4, 6

The American College of Cardiology suggests starting with low-dose ACE inhibitor/ARB (e.g., lisinopril) for non-black patients, and low-dose ARB or calcium channel blocker for black patients 4, 8
Thiazide/thiazide-like diuretic should be added if target not achieved, and calcium channel blocker if further control needed, as recommended by the European Society of Cardiology 4, 8

Blood pressure response should be monitored within 4-6 weeks of treatment initiation, and medications adjusted to maintain BP within target range, according to the American Heart Association 4, 6
Signs of hypoperfusion should be checked if diastolic BP falls below 70 mmHg, and serum potassium and creatinine should be monitored 1-2 times per year, as suggested by the European Society of Cardiology 2, 3, 6

Excessive BP reduction should be avoided, as rapid or excessive lowering of blood pressure may trigger the J-curve effect, especially in patients with coronary disease, according to the American College of Cardiology 2, 3
Pulse pressure should be monitored, and medication timing considered to improve adherence, as recommended by the American Heart Association 3, 4
Beta-blockers should be used with caution, as they are less effective for stroke prevention and cardiovascular event reduction compared to other agents, according to the American Geriatrics Society 8, 9